Dextromethorphan Hydrobromide; Guaifenesin Patent Expiration
Dextromethorphan Hydrobromide; Guaifenesin is Used for treating cough and promoting the removal of mucus from the respiratory tract. It was first introduced by Rb Health Us Llc
Dextromethorphan Hydrobromide; Guaifenesin Patents
Given below is the list of patents protecting Dextromethorphan Hydrobromide; Guaifenesin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mucinex Dm | US6372252 | Guaifenesin sustained release formulation and tablets |
Apr 28, 2020
(Expired) | Rb Hlth |
| Mucinex Dm | US6955821 | Sustained release formulations of guaifenesin and additional drug ingredients |
Apr 28, 2020
(Expired) | Rb Hlth |
| Mucinex Dm | US7838032 | Sustained release of guaifenesin |
Apr 28, 2020
(Expired) | Rb Hlth |
Dextromethorphan Hydrobromide; Guaifenesin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List